Latest News

Image description

Mylan announces $9.9 billion Meda acquisition

Specialty pharmaceutical company Meda is being acquired by Mylan, expanding Mylan's reach into emerging markets, building on its recent specialty and branded generics acquisitions and creating an OTC division worth about $1 billion.